An interventional study of Resistance Exercise Training in Hemodialysis, sponsored by Assiut University. Not yet recruiting at 1 site in Egypt. Open to participants aged 16 Years to 59 Years. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by Assiut University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Kidney Failure, Chronic by Assiut University — 9 open to participants now, 9 under way, none of them phase 3. Kidney Failure, Chronic · Assiut University.
Among the 18 studies in Kidney Failure, Chronic by Assiut University, this one is the only one that started in 2027, is one of 4 with no phase, and was the 18th registered.
2,109 studies on the registry are indexed under Kidney Failure, Chronic; 273 are open to participants now.
Browse Kidney Failure, Chronic studies →9 of the 18 studies in Kidney Failure, Chronic by Assiut University are open now, in 1 country. Recruiting first, the newest first:
Assiut University
Ages 18–60
Assiut University
Ages 18+
Assiut University
Ages 18+
Assiut University
Ages 18+
Assiut University
Ages 18+
By country, each count listing its studies:
Of the 169 Kidney Failure, Chronic studies recruiting now, 109 (64%) set no upper age limit and 32 (19%) stop at 75 or younger; 18 take children under 18; 22 take healthy volunteers.
This study: 16 Years to 59 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 1 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 104 is above the median of 57 across 1,569 interventional studies indexed under Kidney Failure, Chronic.
Median enrollment 86 across the 5 interventional studies, 100 across the 13 observational. Of the 3 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Assiut University is the lead sponsor of 5,081 studies on the registry; 2,179 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
5 of the studies in Kidney Failure, Chronic by Assiut University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07936344Assiut UniversityEffect of Resistance Exercise in Hemodialysis Patients | 2027-07-15 |
| NCT07803237Assiut UniversityPredictors of Rapid CKD Progression | 2027-09-01 |
| NCT07821788Assiut UniversityTwice vs Thrice Weekly Hemodialysis: Clinical Outcomes and Quality of Life | 2027-09-10 |
| NCT07820150Assiut UniversityHyperparathyroidism and Dialysis Adequacy in Hemodialysis Patients | 2027-09-10 |
| NCT07817953Assiut UniversityAVF Awareness Among Advanced CKD Patients | 2027-09-10 |
Add all 5 to your calendar (.ics) → With an account.
Among the 18 studies in Kidney Failure, Chronic by Assiut University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate the effect of a resistance exercise program on patients undergoing hemodialysis, assessing its impact on physical performance, health-related quality of life and overall clinical outcomes
This study is designed as a clinical investigation to assess the comprehensive effects of structured resistance exercise training in patients receiving hemodialysis. The protocol involves implementing a supervised exercise regimen to evaluate key physiological and clinical endpoints, including changes in muscle strength, functional capacity, biochemical markers, and overall health-related quality of life. Regular monitoring and assessments will be conducted throughout the study period to track patient progress, safety, and intervention efficacy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Hemoglobin (Hb)
The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients in this group will participate in a structured resistance exercise training program during or between hemodialysis sessions.
Behavioral: Resistance Exercise Training
Patients in this group receive standard care and lifestyle advice during maintenance hemodialysis without participating in the structured resistance exercise program.
Participants will undergo a structured resistance training program using specific weights or elastic bands. The exercise sessions will be performed under supervision to ensure safety and adherence, targeting major muscle groups to improve physical fitness and strength.
Change in Muscle Strength
Evaluation of muscle strength improvement measured using standard assessment tools (such as dynamometry) before and after the intervention.
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jan 2027; primary completion for Jul 2027, 6 months later.
Of 347 non-industry interventional studies with no phase under Kidney Failure, Chronic, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 47. This study's planned 6 months is below that.
Counting every sponsor, half of 425 studies reached it within 22 months; a quarter within 8 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.